FDA Adverse Event Injury Summary report: N

EMATRIX

MDR report key: 16440052 · Received February 24, 2023

Report

Report Number
3003772750-2023-00001
Event Type
Injury
Date Received
February 24, 2023
Date of Event
July 14, 2020
Report Date
February 24, 2023
Manufacturer
CANDELA CORPORATION
Product Code
GEX
PMA / PMN Number
K101321
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

ALLEGED EVENT OCCURRED IN 2020. A REVIEW OF THE SERVICE HISTORY FOR EMATRIX:(B)(4) REVEALS NO SIMILAR EVENTS ON OR BEFORE (B)(6), 2020. INFORMATION ON SYSTEM SETTINGS/TECHNIQUES IS UNAVAILABLE. AS A RESULT, IT IS UNDETERMINABLE IF THE CUSTOMER USED THE CORRECT SYSTEM SETTINGS/TECHNIQUE AS DESCRIBED IN THE TREATMENT GUIDELINES FOR THE DEVICE IN USE. THEREFORE, THE INVESTIGATION FINDINGS DO NOT LEAD TO A CLEAR CONCLUSION ABOUT THE CAUSE OF THE REPORTED EVENT; CAUSE NOT ESTABLISHED. REVIEW OF RISK MANAGEMENT DOCUMENTS DEMONSTRATE THAT THE REPORTED RISK IS CAPTURED AND ASSESSED. NO FURTHER CORRECTIVE ACTIONS REQUIRED FOR THIS COMPLAINT AT THIS TIME. RISK INFORMATION IS THEN SUBJECT TO PERIODIC RISK REVIEWS AND TREND TRACKING, WHICH MAY REQUIRE ADDITIONAL ACTIONS AND/OR REVIEW.

Description of Event or Problem · 0

AN ADVOCATE FOR A PATIENT REPORTED AN ADVERSE EVENT ON (B)(6), 2023, TO CANDELA LEGAL DEPARTMENT, ALLEGING THAT THE PATIENT WAS TREATED "ON OR ABOUT (B)(6), 2020" AT A CLINIC IN RHODE ISLAND. IT WAS REPORTED THAT THE PATIENT HAD "AN EMATRIX SUBLIME LASER TREATMENT." IT WAS REPORTED THAT THE PATIENT, "SUSTAINED SEVERE BURNS TO HER FACE, RESULTING IN PERMANENT SCARRING AND DISFIGUREMENT" AND ALLEGED THAT PATIENT WAS "PHYSICALLY INJURED, EXPERIENCED CONSCIOUS PAIN AND SUFFERING AND SEVERE PERMANENT SCARRING." NO FURTHER DETAILS AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2023112 EMATRIX EMATRIX GEX CANDELA CORPORATION EMATRIX:

Patients

Seq Age Sex Outcome Treatment
1 Female Other